Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
141 results:
1. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
[TBL] [Abstract] [Full Text] [Related]
2. Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma.
Mateoiu C; Palicelli A; Maloberti T; De Biase D; De Leo A; Lindh M; Bohlin KS; Stolnicu S
Pathol Res Pract; 2024 Mar; 255():155181. PubMed ID: 38340583
[TBL] [Abstract] [Full Text] [Related]
3. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
Chu B; Wang Y; Yang J; Dong B
Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
[TBL] [Abstract] [Full Text] [Related]
4. High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract] [Full Text] [Related]
5. A novel cuproptosis-related gene prognostic signature in colon adenocarcinoma.
Su Y; Zhang K
Can J Physiol Pharmacol; 2023 Nov; 101(11):589-598. PubMed ID: 37698225
[TBL] [Abstract] [Full Text] [Related]
6. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
[TBL] [Abstract] [Full Text] [Related]
7. A novel investigation into an E2F transcription factor-related prognostic model with seven signatures for colon cancer patients.
Shen X; Su Z; Dou Y; Song X
IET Syst Biol; 2023 Aug; 17(4):187-197. PubMed ID: 37431829
[TBL] [Abstract] [Full Text] [Related]
8. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.
Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H
BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive analyses of cuproptosis-related gene cdkn2a on prognosis and immunologic therapy in human tumors.
Zhang D; Wang T; Zhou Y; Zhang X
Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
[TBL] [Abstract] [Full Text] [Related]
10. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis.
Qin Y; Liu Y; Xiang X; Long X; Chen Z; Huang X; Yang J; Li W
Mol Cancer; 2023 Mar; 22(1):59. PubMed ID: 36959665
[TBL] [Abstract] [Full Text] [Related]
11. ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma.
Yang HD; Jin XX; Gu BB; Yu-Zhang ; Li D; Yan LL
BMC Gastroenterol; 2023 Feb; 23(1):48. PubMed ID: 36823542
[TBL] [Abstract] [Full Text] [Related]
12. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus.
Ruano APC; de Jesus Ferreira Costa D; Braun AC; Torres JA; Barbosa PHP; Abdallah EA; Barberan C; Souza E Silva V; Bovolim G; Buim MEC; da Silva Alves V; Riechelmann RP; Chinen LTD
Pathol Res Pract; 2023 Mar; 243():154327. PubMed ID: 36731178
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of p16, p21, and Ki67 expression at the invasive front of colorectal cancers.
Kin R; Hoshi D; Fujita H; Kosaka T; Takamura H; Kiyokawa E
Pathol Int; 2023 Feb; 73(2):81-90. PubMed ID: 36484761
[TBL] [Abstract] [Full Text] [Related]
14. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract] [Full Text] [Related]
15. Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon cancer Predicts a Poor prognosis.
Wu T; Zhang X; Xing L; Pan D; Liu P; Ding R; Yang R; Yang X; Li Y
Dis Markers; 2022; 2022():5883101. PubMed ID: 35677634
[TBL] [Abstract] [Full Text] [Related]
16. Identification and validation of EMT-immune-related prognostic biomarkers cdkn2a, CMTM8 and ILK in colon cancer.
Kang N; Xie X; Zhou X; Wang Y; Chen S; Qi R; Liu T; Jiang H
BMC Gastroenterol; 2022 Apr; 22(1):190. PubMed ID: 35429970
[TBL] [Abstract] [Full Text] [Related]
17. The Role of Autophagy in Tumor Immune Infiltration in colorectal cancer.
Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
[TBL] [Abstract] [Full Text] [Related]
18. Mesothelioma and colorectal cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
[TBL] [Abstract] [Full Text] [Related]
19.
Lee CC; Kuo YC; Hu JM; Chang PK; Sun CA; Yang T; Li CW; Chen CY; Lin FH; Hsu CH; Chou YC
World J Gastroenterol; 2021 Sep; 27(34):5737-5752. PubMed ID: 34629798
[TBL] [Abstract] [Full Text] [Related]
20. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
[TBL] [Abstract] [Full Text] [Related]
[Next]
